Literature DB >> 3499301

Glycosylated hemoglobin as an index of the prevalence and severity of diabetes in biethnic Fiji.

P L Hoskins1, D J Handelsman, T Hannelly, M Silink, D K Yue, J R Turtle.   

Abstract

Glycosylated hemoglobin was compared with fasting blood glucose as a screening test for diabetes mellitus and as an index of the severity of diabetes in biethnic (Melanesian and Indian) Fiji. Age-adjusted diabetes prevalence in the test sample was higher in Indians by either criterion. According to the hemoglobin A1 criterion, Melanesians had prevalence rates of 8.2% (males) and 15.8% (females) compared to 17.0% (males) and 24.3% (females) in Indians. In contrast, fasting blood glucose criteria (WHO) gave higher rates in each group. Hemoglobin A1 levels were higher overall in Indians and females. The predictive value of an elevated fasting blood glucose test for an elevated hemoglobin A1 was 20.0% in Melanesians and 60.7% in Indians while that of a normal fasting blood glucose test for a normal hemoglobin A1 was 89.4% in Melanesians and 89.3% in Indians. The proportion of Indians with elevated hemoglobin A1 who were severely hyperglycemic was almost 7 times higher (40.9% vs. 5.8%) than that of Melanesians. The ethnic difference in the predictive value of fasting blood glucose levels for hemoglobin A1 levels appears to be related to the greater severity of hyperglycemia of diabetic Indians compared to diabetic Melanesians. Hemoglobin A1 levels provide information on both the qualitative as well as quantitative differences in diabetes between ethnic groups.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499301     DOI: 10.1016/s0168-8227(87)80049-9

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  1 in total

1.  Diabetes incidence and projections from prevalence surveys in Fiji.

Authors:  Stephen Morrell; Sophia Lin; Isimeli Tukana; Christine Linhart; Richard Taylor; Penina Vatucawaqa; Dianna J Magliano; Paul Zimmet
Journal:  Popul Health Metr       Date:  2016-11-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.